Healthmyne Inc
Madison, US · Founded 2013 · 2 employees on LinkedIn · 4 known investors
Find your way into Healthmyne Inc
Sign up to see every warm intro you have to Healthmyne Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Healthmyne Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HealthMyne develops QIDS, a quantitative imaging and clinical decision support platform for oncology care teams that tracks incidental findings, supports tumor conference preparation, and provides quantitative imaging metrics such as lesion volume and texture analysis. It is used by radiologists and clinicians to manage patients across screening, diagnosis, and treatment.
Founders & leadership


Board
Investors · 4
How we know: av.vc · Not right? Tell us
How we know: Ascension Ventures's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$21.9M disclosed across 2 rounds · 2015–2018
▶$15MraisedAug 2018 · 21 investors · Other Health CareRule 506(b)
- John KuelperDirector
- Linda PeitzmanExecutive Officer
- Dan MalvenDirector
- Scott ButtonDirector
- Milton Silva-CraigDirector
- T. Rockwell MackieDirector
- Arvind SubramanianExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$6.9MraisedSep 2016 · 23 investors · Other Health CareRule 506(b)
- Thomas Rockwell MackieDirector
- Roger ChyllaExecutive Officer, Director
- Greg RobinsonDirector
- Hao WangExecutive Officer
- Praveen SinhaExecutive Officer, Director
- Scott ButtonDirector
- Arvind SubramanianExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $6.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Science Foundation | Phase II | 2015 | $742.1K |
| National Science Foundation | Phase I | 2014 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Healthmyne Inc do?
- HealthMyne develops QIDS, a quantitative imaging and clinical decision support platform for oncology care teams that tracks incidental findings, supports tumor conference preparation, and provides quantitative imaging metrics such as lesion volume and texture analysis. It is used by radiologists and clinicians to manage patients across screening, diagnosis, and treatment.
- Who are Healthmyne Inc's investors?
- Healthmyne Inc's investors include Alumni Ventures, Ascension Ventures, Bascom Ventures, 4490 Ventures.
- How much funding has Healthmyne Inc raised?
- Healthmyne Inc has disclosed $21.9M raised across 2 rounds.
- Where is Healthmyne Inc headquartered?
- Healthmyne Inc is headquartered in Madison, US.



